A New, Minimally Invasive, Robotic Treatment for Patients with an Enlarged Prostate

Aquablation therapy is a new type of surgical treatment for Benign Prostatic Hyperplasia (BPH). Saint Vincent Medical Group is proud to offer this advanced, minimally invasive treatment.

BPH, or an enlarged prostate, is a non-cancerous condition where the prostate has grown to be larger than normal. If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones, and incontinence.

Aquablation therapy includes:

  • Advanced, minimally invasive treatment that uses the power of water delivered with robotic precision to provide best-in-class and long-lasting symptom relief.
  • Resective procedure, which means that the prostate tissue causing symptoms is surgically removed. No incision is made in the abdomen, as the prostate is reached through the urethra.
  • AquaBeam Robotic System, first FDA-cleared, surgical robot utilizing automated tissue resection for the treatment of Lower Urinary Tract Symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
  • Low rates of irreversible complications, regardless of prostate size or shape.
  • Safe and effective treatment for BPH patients suffering from lower urinary tract symptoms which affect the bladder, prostate, and urethra and impact the ability to hold urine and empty the bladder.